STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

from hospitals to pharma Biotech analyst Brian Skorney and CEO Daphne Zohar weigh… Biotech analyst Brian Skorney and CEO ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Dr. Beddingfield is a physician-scientist and serial biotechnology entrepreneur, and brings more than 20 years of life sciences leadership to Rubedo. He was founder, president, chief executive and ...

In August, Trevena underwent a reverse stock split, a move often enacted when a company’s share price dips too low. The split wasn’t enough to stave off delisting, with Nasdaq removing Trevena’s stock ...

Neurotech International Ltd. (AU:NTI) has released an update. Neurotech International Ltd. has appointed Dr. Anthony Filippis as its new CEO, ...

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

Edesa Biotech (EDSA) has released an update. Edesa Biotech’s CEO and Founder, Par Nijhawan, has made a strategic investment of up to $5 million in the company, demonstrating strong confidence in ...

Former Binance CEO Changpeng Zhao rules out returning to the crypto exchange after prison term, instead focusing on a new ...

Emergent BioSolutions raised its revenue guidance and dropped a going concern warning. Its CEO is billing this next chapter ...

If effective, Lamassu Biotech’s innovative gene therapy could eliminate the need for surgery or chemotherapy for some types of hard-to-treat cancer, said CEO Dr. Gabi Hanna. Lamassu Biotech has ...

TORONTO - Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has announced a new investment agreement involving its CEO, Dr. Par Nijhawan. Under the terms of the agreement, ...